Literature DB >> 32678706

Cardiometabolic risk factors are associated with immune cell mitochondrial respiration in humans.

Theodore M DeConne1, Eric R Muñoz1, Faria Sanjana1, Joshua C Hobson1, Christopher R Martens1.   

Abstract

Modifiable cardiometabolic risk factors induce the release of proinflammatory cytokines and reactive oxygen species from circulating peripheral blood mononuclear cells (PBMCs), resulting in increased cardiovascular disease risk and compromised immune health. These changes may be driven by metabolic reprogramming of PBMCs, resulting in reduced mitochondrial respiration; however, this has not been fully tested. We aimed to determine the independent associations between cardiometabolic risk factors including BMI, blood pressure, fasting glucose, and plasma lipids with mitochondrial respiration in PBMCs isolated from generally healthy individuals (n = 21) across the adult lifespan (12 men/9 women; age, 56 ± 21 yr; age range, 22-78 yr; body mass index, 27.9 ± 5.7 kg/m2; blood pressure, 123 ± 16/72 ± 10 mmHg; glucose, 90 ± 14 mg/dL; low-density lipoprotein cholesterol (LDL-C), 111 ± 22 mg/dL; and high-density lipoprotein cholesterol (HDL-C), 62 ± 16 mg/dL). PBMCs were isolated from whole blood by density-dependent centrifugation and used to assess mitochondrial function by respirometry. Primary outcomes included basal and maximal oxygen consumption rate (OCR), which were subsequently used to determine spare respiratory capacity and OCR metabolic potential. After we corrected for systolic blood pressure (SBP), diastolic blood pressure (DBP), and blood glucose, LDL-C was negatively associated with maximal respiration (r = -0.56, P = 0.016), spare respiratory capacity (r = -0.58, P = 0.012), and OCR metabolic potential (r = -0.71, P = 0.0011). In addition, SBP was negatively associated with OCR metabolic potential (r = -0.62, P = 0.0056) after we corrected for DBP, blood glucose, and LDL-C. These data suggest a link between blood cholesterol, SBP, and mitochondrial health that may provide insight into how cardiometabolic risk factors contribute to impaired immune cell function.NEW & NOTEWORTHY Independent of other cardiometabolic risk factors, low-density lipoprotein cholesterol, and systolic blood pressure were found to be negatively associated with several parameters of mitochondrial respiration in peripheral blood mononuclear cells of healthy adults. These data suggest that low-density lipoprotein cholesterol and systolic blood pressure may induce metabolic reprogramming of immune cells, contributing to increased cardiovascular disease risk and impaired immune health.

Entities:  

Keywords:  cardiovascular disease; cholesterol; immune cells; mitochondrial dysfunction; peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2020        PMID: 32678706      PMCID: PMC7473919          DOI: 10.1152/ajpheart.00434.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  53 in total

Review 1.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 2.  Cholesterol crystals and inflammation.

Authors:  Alena Grebe; Eicke Latz
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

3.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

Review 4.  Enhancing Mitochondrial Health to Treat Hypertension.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Curr Hypertens Rep       Date:  2018-08-17       Impact factor: 5.369

5.  Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy.

Authors:  Delyth Graham; Ngan N Huynh; Carlene A Hamilton; Elisabeth Beattie; Robin A J Smith; Helena M Cochemé; Michael P Murphy; Anna F Dominiczak
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

6.  Modulation of vascular endothelial function by low-density lipoprotein cholesterol with aging: influence of habitual exercise.

Authors:  Ashley E Walker; Iratxe Eskurza; Gary L Pierce; Phillip E Gates; Douglas R Seals
Journal:  Am J Hypertens       Date:  2008-12-25       Impact factor: 2.689

7.  Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British Hypertension Society protocol, the International Protocol and the Association for the Advancement of Medical Instrumentation standards.

Authors:  Hernan Polo Friz; Rita Facchetti; Laura Primitz; Luca Beltrame; Valentina Galbiati; Aristodemo Ricioppo; Michele Bombelli; Roberto Sega
Journal:  Blood Press Monit       Date:  2009-10       Impact factor: 1.444

8.  Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.

Authors:  Matthew J Rossman; Jessica R Santos-Parker; Chelsea A C Steward; Nina Z Bispham; Lauren M Cuevas; Hannah L Rosenberg; Kayla A Woodward; Michel Chonchol; Rachel A Gioscia-Ryan; Michael P Murphy; Douglas R Seals
Journal:  Hypertension       Date:  2018-04-16       Impact factor: 10.190

9.  Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host.

Authors:  Anna Schurich; Laura J Pallett; Danyal Jajbhay; Jessica Wijngaarden; Itziar Otano; Upkar S Gill; Navjyot Hansi; Patrick T Kennedy; Eleni Nastouli; Richard Gilson; Christian Frezza; Sian M Henson; Mala K Maini
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

10.  Mitochondria-targeted antioxidant therapy with MitoQ ameliorates aortic stiffening in old mice.

Authors:  Rachel A Gioscia-Ryan; Micah L Battson; Lauren M Cuevas; Jason S Eng; Michael P Murphy; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2017-10-26
View more
  2 in total

Review 1.  Pathophysiology of Heart Failure: A Role for Peripheral Blood Mononuclear Cells Mitochondrial Dysfunction?

Authors:  François Sauer; Marianne Riou; Anne-Laure Charles; Alain Meyer; Emmanuel Andres; Bernard Geny; Samy Talha
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

2.  Protein Supplementation Does Not Maximize Adaptations to Low-Volume High-Intensity Interval Training in Sedentary, Healthy Adults: A Placebo-Controlled Double-Blind Randomized Study.

Authors:  Dejan Reljic; Nilas Zieseniss; Hans J Herrmann; Markus F Neurath; Yurdagül Zopf
Journal:  Nutrients       Date:  2022-09-20       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.